Clinical trials
Hyperlipoproteinemia Type II trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 3 |
| Arrowhead Pharmaceuticals | 2 |
| Verve Therapeutics, Inc. | 2 |
| LipimetiX Development, LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Pfizer | 1 |
| The University of Western Australia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 11 |
| Hypercholesterolemia | 6 |
| Hypertriglyceridemia | 3 |
| Homozygous Familial Hypercholesterolemia | 2 |
| Hyperlipidemias | 2 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Dyslipidemias | 1 |
Trials
Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.